Ha Tay Pharmaceutical JSC (HNX:DHT)

Ha Tay Pharmaceutical JSC Revenue

Ha Tay Pharmaceutical JSC had revenue of 638.80B VND in the quarter ending September 30, 2025, with 17.32% growth. This brings the company's revenue in the last twelve months to 2.25T, up 11.57% year-over-year. In the year 2024, Ha Tay Pharmaceutical JSC had annual revenue of 2.09T with 4.35% growth.

• Revenue (ttm): 2.25T
• Revenue Growth: +11.57%
• P/S Ratio: 2.81
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 6.33T

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.09T	87.05B	4.35%
Jan 1, 2024	2.00T	161.91B	8.81%
Dec 31, 2022	1.84T	228.03B	14.17%
Dec 31, 2021	1.61T	-397.11B	-19.79%
Jan 1, 2021	2.01T	-35.76B	-1.75%